FI935780A - HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten - Google Patents

HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten Download PDF

Info

Publication number
FI935780A
FI935780A FI935780A FI935780A FI935780A FI 935780 A FI935780 A FI 935780A FI 935780 A FI935780 A FI 935780A FI 935780 A FI935780 A FI 935780A FI 935780 A FI935780 A FI 935780A
Authority
FI
Finland
Prior art keywords
aids
treatment
protease inhibitors
hiv protease
inhibitors useful
Prior art date
Application number
FI935780A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI935780A0 (fi
Inventor
Bruce Anthony Dressman
Marlys Hammond
Stephen Warren Kaldor
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI935780A0 publication Critical patent/FI935780A0/fi
Publication of FI935780A publication Critical patent/FI935780A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60N-oxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
FI935780A 1992-12-22 1993-12-21 HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten FI935780A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99562192A 1992-12-22 1992-12-22

Publications (2)

Publication Number Publication Date
FI935780A0 FI935780A0 (fi) 1993-12-21
FI935780A true FI935780A (fi) 1994-06-23

Family

ID=25542022

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935780A FI935780A (fi) 1992-12-22 1993-12-21 HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten

Country Status (15)

Country Link
EP (1) EP0609625A1 (es)
JP (1) JPH06256277A (es)
KR (1) KR940014336A (es)
CN (1) CN1092410A (es)
AU (1) AU5252993A (es)
BR (1) BR9305161A (es)
CA (1) CA2112052A1 (es)
CO (1) CO4180513A1 (es)
CZ (1) CZ281393A3 (es)
FI (1) FI935780A (es)
HU (1) HUT69703A (es)
IL (1) IL108098A0 (es)
MX (1) MX9308025A (es)
NO (1) NO934721L (es)
PL (1) PL301578A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5747540A (en) * 1996-10-21 1998-05-05 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
CA2401749A1 (en) 2000-03-23 2001-09-27 Elan Pharmaceuticals, Inc. Compounds and methods to treat alzheimer's disease
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
EP1666452A2 (en) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
AU7622500A (en) * 2000-09-29 2002-07-01 Neurogen Corp High affinity small molecule c5a receptor modulators
IL159897A0 (en) * 2001-07-19 2004-06-20 Cv Therapeutics Inc Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
EP1432674A2 (en) 2001-10-04 2004-06-30 Elan Pharmaceuticals, Inc. Hydroxypropylamines
WO2004058686A1 (en) 2002-04-30 2004-07-15 Elan Pharmaceuticals, Inc. Hydroxypropyl amides for the treatment of alzheimer’s disease
JP4721214B2 (ja) * 2004-09-14 2011-07-13 日本曹達株式会社 ピリジルメチルカルバミン酸エステル化合物及びピリジルメチルアミン化合物の製造方法
JP4698991B2 (ja) * 2004-09-14 2011-06-08 日本曹達株式会社 ピリジルメチルカルバミン酸エステル化合物、その製造方法及びピリジルメチルアミン化合物の製造方法
JP2008535863A (ja) 2005-04-08 2008-09-04 コメンティス,インコーポレーテッド β−セクレターゼ活性を阻害する化合物およびその使用方法
WO2010002994A1 (en) * 2008-07-01 2010-01-07 Purdue Research Foundation Nonpeptide hiv-1 protease inhibitors
CN110872251A (zh) * 2019-11-28 2020-03-10 卡博金艾美斯医药(上海)有限公司 N-乙基吡啶甲胺三氟乙酸盐及其晶体、制备工艺和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361341A3 (en) * 1988-09-28 1991-07-03 Miles Inc. Therapeutics for aids based on inhibitors of hiv protease
WO1991008221A1 (en) * 1989-12-04 1991-06-13 Wisconsin Alumni Research Foundation Peptide inhibitors of hiv protease
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives

Also Published As

Publication number Publication date
NO934721L (no) 1994-06-23
HU9303677D0 (en) 1994-04-28
MX9308025A (es) 1994-08-31
PL301578A1 (en) 1994-06-27
NO934721D0 (no) 1993-12-20
AU5252993A (en) 1994-07-07
CZ281393A3 (en) 1994-07-13
CA2112052A1 (en) 1994-06-23
FI935780A0 (fi) 1993-12-21
KR940014336A (ko) 1994-07-18
EP0609625A1 (en) 1994-08-10
JPH06256277A (ja) 1994-09-13
HUT69703A (en) 1995-09-28
CO4180513A1 (es) 1995-06-07
IL108098A0 (en) 1994-04-12
BR9305161A (pt) 1994-11-01
CN1092410A (zh) 1994-09-21

Similar Documents

Publication Publication Date Title
FI955315A (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
NO893400L (no) Hiv protease inhibitorer egnet for behandling av aids.
EP0604182A3 (en) HIV protease inhibiting compounds.
BR9407782A (pt) Inibidores de protease do HIV
NO905428D0 (no) Fremgangsmaate for fremstilling av hiv-proteaseinhibitorerfor behandling av aids.
IL102428A0 (en) Inhibitors of hiv protease useful for the treatment of aids
FI935780A (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
AU4135493A (en) Inhibitors of HIV protease useful for the treatment of AIDS
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
EP0912170A4 (en) HIV PROTEASE INHIBITORS USEFUL IN AIDS TREATMENT
EP0914125A4 (en) HIV protease inhibitors, useful in AIDS treatment.
ZA928563B (en) HIV protease inhibitors useful for the treatment of AIDS.
GB9613488D0 (en) HIV protease inhibitors useful in the treatment of aids
ZA939475B (en) Inhibitors of HIV protease useful for the treatment of Aids
ZA892627B (en) Hiv protease inhibitors useful for the treatment of aids
ZA896430B (en) Hiv protease inhibitors useful for the treatment of aids
ZA9010125B (en) Hiv protease inhibitors useful for the treatment of aids
AU620084C (en) HIV protease inhibitors useful for the treatment of aids
GB9609663D0 (en) HIV Protease inhibitors useful for the treatment of aids
NO920023L (no) Hiv-proteaseinhibitorer
AU3270689A (en) Hiv protease inhibitors useful for the treatment of aids

Legal Events

Date Code Title Description
FD Application lapsed